PROFIL

BMS

Laboratoire pharmaceutique Bristol-Myers Squibb France.

Aucun article n’a été trouvé

Fil Twitter

Bristol-Myers Squibb
Join us this morning at 10:30 a.m. EDT for our Q1 earnings call. Learn more: t.co/00himFXxTf t.co/wiPiJaYbG0
Bristol-Myers Squibb
Reporting Q3 results: Revenues $5.2 billion, GAAP EPS $0.91 and non-GAAP EPS $0.94 t.co/hKg5t6lbHu. $BMY t.co/kXacJCzEbZ
Bristol-Myers Squibb
#MEDIA: European Commission approves new dosing options for an I-O therapy. Read more: t.co/63F7M4ZV7T… t.co/5cRYxvKggr
Bristol-Myers Squibb
From an early fascination with dinosaurs, #RedwoodCity based #cancer researcher Bo Barnhart has always been drawn t… t.co/2MgplzFrCs
Bristol-Myers Squibb
Attending the Boston #NASH Summit? Learn more about PRO-C3, a biomarker under investigation: t.co/p0nQL8cAoH t.co/CFxFTnUqGB
Bristol-Myers Squibb
#DYK Joe Szustakowski, our head of translational #bioinformatics, worked on the initial sequencing of the Human Gen… t.co/8Tjhr3Mm8j
Bristol-Myers Squibb
DYK Nils Lonberg and Alan Korman, early #ImmunoOncology pioneers, run our research facility in #RedwoodCity, where… t.co/gVMkKYaCGC
Bristol-Myers Squibb
The Asian-Pacific region has the highest rate of #EsophagealCancer, accounting for about 75% of all cases in the wo… t.co/S9bBX4dStK
Bristol-Myers Squibb
We’re using music to inspire people to take action and learn about #AFib (a type of irregular heartbeat) not caused… t.co/TZmxVrLwFb
Bristol-Myers Squibb
Executive director of #ImmunoOncology Mike Quigley and his team are passionate about researching why some #cancerst.co/bfTAsHQmgw

Commentaires sur vih.org

Commentaires (0)